Sign In
Buy VTRS
$16.39
+0.120 (+0.738%)
At Close: Jul 13, 2026
Why Viatris (VTRS) is a Top Value Stock for the Long-Term
10:41am, Friday, 10'th Jul 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
VTRS or DHR: Which Is the Better Value Stock Right Now?
12:40pm, Thursday, 09'th Jul 2026
Investors interested in Medical Services stocks are likely familiar with Viatris (VTRS) and Danaher (DHR). But which of these two companies is the best option for those looking for undervalued stocks?
Should Value Investors Buy Viatris (VTRS) Stock?
10:41am, Thursday, 09'th Jul 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
3 Dirt Cheap Healthcare Shares Under $30 to Buy Right Now
01:19pm, Tuesday, 07'th Jul 2026
Healthcare has been an unloved corner of the market in 2026, but that neglect has created a rare setup: quality names trading in single-digit and low-double-digit territory while still throwing off ca
Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?
01:09pm, Monday, 06'th Jul 2026
Growth premium vs. value recovery, one trades at 33x forward earnings while the other navigates debt reduction and biosimilar expansion.
Viatris (VTRS) is a Great Momentum Stock: Should You Buy?
01:01pm, Thursday, 02'nd Jul 2026
Does Viatris (VTRS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Viatris to Report Second-Quarter 2026 Financial Results on August 6, 2026
06:59am, Wednesday, 01'st Jul 2026
PITTSBURGH, July 1, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced it will report second-quarter 2026 financial results on Thursday, August 6, 2026. Com
Here's Why Viatris (VTRS) is a Strong Momentum Stock
10:50am, Monday, 29'th Jun 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
VR-205 Met Primary Endpoint and Key Secondary Endpoints and Was Well Tolerated VR-205 Efficacy and Safety Profile in Japanese Patients Was Consistent with the Profile Observed in Global Studies Japa
Viatris (VTRS) is a Top-Ranked Value Stock: Should You Buy?
10:41am, Wednesday, 24'th Jun 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Viatris Soared 54%: Time To Be More Careful (Rating Downgrade)
12:55pm, Tuesday, 23'rd Jun 2026
Viatris Inc. ends the first half of 2026 on a high note. On May 8, its stock reached a 52-week high of $17.53. One of the key drivers behind Viatris' recent rally is its pipeline, which includes more
VTRS vs. DHR: Which Stock Is the Better Value Option?
12:41pm, Tuesday, 23'rd Jun 2026
Investors interested in Medical Services stocks are likely familiar with Viatris (VTRS) and Danaher (DHR). But which of these two companies is the best option for those looking for undervalued stocks?
Are Investors Undervaluing Viatris (VTRS) Right Now?
10:40am, Tuesday, 23'rd Jun 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
3 Generic Drug Stocks to Watch as New Growth Drivers Emerge
12:50pm, Friday, 05'th Jun 2026
Sandoz, Teva and Viatris target biosimilars, complex generics and specialty drugs as new growth drivers reshape the Medical - Generic Drugs industry.
Here's Why Viatris (VTRS) is a Strong Value Stock
10:41am, Thursday, 04'th Jun 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
